Feb 28, 2025 / 08:00AM GMT
Trond Williksen - Benchmark Holdings PLC - Chief Executive Officer
Good morning to all of you and welcome to this quarterly presentation for Benchmark. I'm Trond Williksen, and as usual I'm here together with our CFO Septima Maguire, and we are going to give you an update on our first quarter results for financial year 2025. We're following the normal program starting with the highlights, moving to give you a little bit more on the business. Septima will take you through the more detailed financials before we end with sharing an overview on the outlooks for the company and for the quarters, and the time that we have ahead. At the very end, there will of course be an opportunity for Q&A.
And starting with the highlights, let me start out saying that this has really been a steppingstone quarter for us in Benchmark, where the main focus has been on moving towards the closing of the genetics deal as well as preparing for the subsequent streamlining of the company, bringing it into the next phase of its development. In terms of the sale of genetics, we signed a deal with Noble Holdings back in
Q1 2025 Benchmark Holdings PLC Analyst / Investor Webcast Transcript
Feb 28, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers